Multiple Sclerosis

MS Disability, Symptoms Are Worse in Non-White Patients, Study Finds

September 16th 2021, 9:30pm


Non-white patients with multiple sclerosis (MS), particularly African American and Hispanic American patients, were found to experience a higher level of overall disability and more severe symptoms, highlighting current disparities in this disease.

Study: COVID-19 Barriers Halted, Delayed Research on MS Rehabilitation, Quality of Life

September 8th 2021, 8:40pm


In a survey, researchers indicated that the COVID-19 pandemic has placed extra barriers, including a lack of accessibility to patients and competing responsibilities, that have resulted in halts or delays to research on multiple sclerosis (MS) rehabilitation and quality of life.

Study Finds Depression May Increase Mortality Risks in Patients With MS

September 1st 2021, 8:00pm


Patients who have both multiple sclerosis (MS) and depression may have a higher risk of death and vascular disease compared with people who only have 1 or neither of those conditions.

T-Cell Responses Still Detected in Patients With MS Receiving Ocrelizumab and Recovered From COVID-19

August 27th 2021, 7:00pm


Patients with multiple sclerosis (MS) who have recovered from COVID-19 and received the B-cell depleting therapy ocrelizumab for at least 1 year were observed to still have T-cell responses.

Study Finds Potential Biomarkers for Cognitive Decline in MS Over 5-Year Period

August 16th 2021, 9:40pm


Investigators found that biomarkers for neurodegeneration and inflammation could also aid providers in detecting declines in cognition and information processing speed in patients with multiple sclerosis (MS) over a 5-year period.

Single-Leg Heel Test May Be Useful Tool for Differentiating Limb Strength in MS

August 12th 2021, 10:30am


The single-leg heel test was able to differentiate between weaker and stronger limbs in patients with multiple sclerosis (MS) and in healthy controls, suggesting that the test could prove useful for identifying impaired muscle performance.

Diagnose, Monitor, Treat: How AI’s 3-Pronged Approach Can Help to Propel Progress in MS

August 5th 2021, 11:00am


Using artificial intelligence (AI) effectively may help to revolutionize the diagnosis, monitoring, and treatment of multiple sclerosis (MS), as well as optimizing understanding of the immune-mediated disease.

Study Identifies Potential Biomarkers for MS-Related Cognitive Decline

August 2nd 2021, 6:45pm


Results of an observational study suggest retinal nerve fiber layer atrophy and the presence of oligoclonal bands may serve as biomarkers for cognitive decline in patients with multiple sclerosis (MS).

MS Wrap-up: Ancestral Ties to MS Prevalence, S1P Therapy Advances, and More

July 31st 2021, 11:03am


Here are some of the latest developments in multiple sclerosis (MS) from our sister publication, NeurologyLive®.

Future of MS Management

July 29th 2021, 1:05pm


Key opinion leaders in MS provide closing thoughts on the future of MS treatment including digital therapeutics, new generics, and pipeline drugs on the horizon.